Darapladib inhibits atherosclerosis development in type 2 diabetes mellitus Sprague-Dawley rat model.

CONCLUSION: Our data indicate that darapladib can decrease the foam cells number, iNOS, and ICAM-1 expression in aorta at the early stages of atherosclerosis in T2DM rat model. PMID: 29715185 [PubMed - in process]
Source: Endocrine Regulations - Category: Endocrinology Tags: Endocr Regul Source Type: research